| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/29/1997 | CA1339127C .alpha.,.alpha.-disubstituted aromatics and heteroaromatics as cognitionenhancers |
| 07/29/1997 | CA1339123C Penem derivatives, production and use thereof |
| 07/29/1997 | CA1339096C Novel one step method and polynucleotide compounds for hybridizing to target polynucleotides |
| 07/29/1997 | CA1339085C Cosmetic and pharmaceutical compositions containing benzoyl peroxide andquaternary ammonium salts thereof |
| 07/29/1997 | CA1339077C Liposome-encapsulated vinca alkaloids and their use in combatting tumors |
| 07/29/1997 | CA1339076C Opioid analgesic liposomal delivery - release system |
| 07/29/1997 | CA1339072C Pharmaceutical formulation as well as a process for its preparation |
| 07/29/1997 | CA1339070C Treatment of diseases associated with cysteine deficiency |
| 07/24/1997 | WO1997026535A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | WO1997026523A2 Detection of a leptin receptor variant and methods for regulating obesity |
| 07/24/1997 | WO1997026370A1 Leptin receptor variants |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026335A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | WO1997026331A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 07/24/1997 | WO1997026328A1 Immunotherapy using cytotoxic t lymphocytes (ctl) |
| 07/24/1997 | WO1997026327A1 Compositions and methods for mediating cell cycle progression |
| 07/24/1997 | WO1997026326A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
| 07/24/1997 | WO1997026320A2 Product for inhibition of attachment of h. influenzae to human cells |
| 07/24/1997 | WO1997026300A1 Combinatorial process for preparing substituted indane libraries |
| 07/24/1997 | WO1997026279A1 Synthetic il-10 analogues |
| 07/24/1997 | WO1997026278A1 Synthetic il-10 analogues |
| 07/24/1997 | WO1997026272A1 Leptin receptor variants |
| 07/24/1997 | WO1997026265A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | WO1997026264A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | WO1997026262A1 PYRIDO(3,2,1-ij)-1,3,4-BENZOXADIAZINE DERIVATIVE |
| 07/24/1997 | WO1997026261A1 Pyrido (3,2,1-ij)-1,3,4-benzoxadiazine |
| 07/24/1997 | WO1997026260A1 Isooxacephem derivatives |
| 07/24/1997 | WO1997026258A1 Angiogenesis inhibiting pyridazinamines |
| 07/24/1997 | WO1997026257A1 Hydroxamic acid based collagenase inhibitors |
| 07/24/1997 | WO1997026253A1 Novel benzoyl guanidine derivatives, process for their preparation and their use in the preparation of medicines |
| 07/24/1997 | WO1997026250A1 Integrin receptor antagonists |
| 07/24/1997 | WO1997026247A1 1-arylphthalazine antagonists of excitatory amino acid receptors |
| 07/24/1997 | WO1997026244A1 Chinoline-2-(1h)-ones |
| 07/24/1997 | WO1997026243A1 Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands |
| 07/24/1997 | WO1997026241A1 Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| 07/24/1997 | WO1997026240A1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 07/24/1997 | WO1997026237A1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions |
| 07/24/1997 | WO1997026021A1 Methods, compositions and articles for contraception |
| 07/24/1997 | WO1997026018A1 Methods and compositions for in-vivo detection of oral cancers and precancerous conditions |
| 07/24/1997 | WO1997026014A1 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms |
| 07/24/1997 | WO1997026013A1 Obesity protein formulations |
| 07/24/1997 | WO1997026012A1 Obesity protein formulations |
| 07/24/1997 | WO1997026011A1 Obesity protein formulations |
| 07/24/1997 | WO1997026010A1 Anticoagulant agents useful in treatment of thrombosis |
| 07/24/1997 | WO1997026006A1 Compositions and methods for administering borrelia burgdorferi antigens |
| 07/24/1997 | WO1997026004A1 Obesity protein formulations |
| 07/24/1997 | WO1997026000A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | WO1997025999A1 Peptides for altering osteoblast adhesion |
| 07/24/1997 | WO1997025998A1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same |
| 07/24/1997 | WO1997025994A1 Control of healing process |
| 07/24/1997 | WO1997025993A1 Use of tirilazad for caring for soft tissue edema |
| 07/24/1997 | WO1997025991A1 Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7h-pyrido[3,2,1,ij]-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial |
| 07/24/1997 | WO1997025990A1 High-content famciclovir tablets |
| 07/24/1997 | WO1997025989A1 Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application |
| 07/24/1997 | WO1997025988A1 Methods of treating or preventing pain or nociception |
| 07/24/1997 | WO1997025987A1 Ischemic heart muscle protective agents |
| 07/24/1997 | WO1997025986A1 Intimal thickening inhibitors |
| 07/24/1997 | WO1997025985A1 Tracheal smooth muscle relaxant |
| 07/24/1997 | WO1997025984A1 Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors |
| 07/24/1997 | WO1997025983A1 Indane derivatives for antipsychotic compositions |
| 07/24/1997 | WO1997025981A1 Medical use |
| 07/24/1997 | WO1997025978A1 Method of obtaining perfluorocarbon emulsions for medical purposes |
| 07/24/1997 | WO1997025977A1 Pharmaceutical compositions |
| 07/24/1997 | WO1997025976A1 Anthelmintic paste |
| 07/24/1997 | WO1997025973A1 Compositions for treating hair or skin |
| 07/24/1997 | WO1997025970A1 Cosmetic self-tanning agent having a sunscreen effect |
| 07/24/1997 | WO1997025969A1 Method of inhibiting photoaging of skin |
| 07/24/1997 | WO1997025959A2 Compositions and methods for the prevention and treatment of atherosclerosis and reperfusion injury with magnesium salts |
| 07/24/1997 | WO1997021993A3 Nuclear receptor ligands and ligand binding domains |
| 07/24/1997 | WO1997018300A3 Murine model for human carcinoma |
| 07/24/1997 | WO1997018207A3 Novel macrocyclic compounds as metalloprotease inhibitors |
| 07/24/1997 | WO1997017072A3 Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system |
| 07/24/1997 | WO1997014808A3 Herpesvirus vectors and their uses |
| 07/24/1997 | DE19602206A1 Zubereitungen nichtsteroidaler Analgetika Preparations of non-steroidal analgesics |
| 07/24/1997 | DE19602110A1 Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Zusammensetzungen auf der Basis von Squalen und Sphingolipiden Against bacteria, parasites, protozoa, and viruses mycota effective compositions based on squalene and sphingolipids |
| 07/24/1997 | DE19602108A1 Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Substanzen Against bacteria, parasites, protozoa, and viruses mycota active substances |
| 07/24/1997 | DE19601782A1 Chinolin-2-(1H)one Quinolin-2 (1H) one |
| 07/24/1997 | CA2678707A1 Pharmaceutical compositions comprising ascomycin derivatives |
| 07/24/1997 | CA2243982A1 Tracheal smooth muscle relaxants |
| 07/24/1997 | CA2243717A1 Indane derivatives for antipsychotic compositions |
| 07/24/1997 | CA2243531A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | CA2243505A1 Obesity protein formulations |
| 07/24/1997 | CA2243500A1 Combinatorial process for preparing substituted indane libraries |
| 07/24/1997 | CA2243446A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | CA2243313A1 Compositions and methods for the prevention and treatment of atherosclerosis and reperfusion injury with magnesium salts |
| 07/24/1997 | CA2243295A1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions |
| 07/24/1997 | CA2243275A1 Synthetic il-10 analogues |
| 07/24/1997 | CA2243245A1 Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors |
| 07/24/1997 | CA2242913A1 Hydroxamic acid based collagenase inhibitors |
| 07/24/1997 | CA2242911A1 Peptides for altering osteoblast adhesion |
| 07/24/1997 | CA2242909A1 Isooxacephem derivatives |
| 07/24/1997 | CA2242877A1 Integrin receptor antagonists |
| 07/24/1997 | CA2242775A1 1-arylphthalazine antagonists of excitatory amino acid receptors |
| 07/24/1997 | CA2242716A1 Esters of (9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7h-pyrido[3,2,1,ij]-1,3,4-benzoaxadiazine-6-carboxylic acid) and their use as antibacterial |
| 07/24/1997 | CA2242713A1 Pyrido (3,2,1-ij)-1,3,4-benzoxadiazine |
| 07/24/1997 | CA2242434A1 Pyrido(3,2,1-ij)-1,3,4-benzoxadiazine derivative |
| 07/24/1997 | CA2242376A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | CA2241983A1 Control of healing process |
| 07/24/1997 | CA2241567A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | CA2241565A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |